CVS Group plc Placing Update (1632F)
February 16 2018 - 6:45AM
UK Regulatory
TIDMCVSG
RNS Number : 1632F
CVS Group plc
16 February 2018
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT
FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY,
IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES,
AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF IRELAND OR THE REPUBLIC
OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE
UNLAWFUL TO DO SO.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY
SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR
CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR
ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE
OF ANY SECURITIES OF CVS GROUP PLC IN ANY JURISDICTION IN WHICH ANY
SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL. NEITHER THIS
ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS
OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN
RESPECT OF CVS GROUP PLC.
CAPITALISED TERMS IN THIS ANNOUNCEMENT SHALL HAVE THE SAME
MEANING AS IN THE ANNOUNCEMENT HEADED "PROPOSED ACCELERATED
BOOKBUILD" ISSUED EARLIER TODAY.
16 February 2018
This announcement contains inside information
CVS Group plc
(the "Company")
Placing Update
CVS Group plc (AIM: CVSG), one of the UK's leading providers of
integrated veterinary services, announces that, further to the
announcements made earlier today, the Company has successfully
raised approximately GBP60 million (before expenses) by way of an
accelerated bookbuild. The Placing was heavily oversubscribed and
has received strong support from both existing and new
investors.
In connection with the Placing, the Company will issue 5,581,395
new Ordinary Shares (the "Placing Shares") at a price of 1075 pence
each (the "Placing Price").
The issue of the Placing Shares is being made under existing
authorities and remains subject to Admission, which is expected at
08:00 on Tuesday 20 February.
Participants in the Placing will be contacted by N+1 Singer
shortly to confirm their final allocations and a further
announcement will be made in due course.
For further information please contact:
CVS Group plc
Simon Innes, Chief Executive Tel: 01379 644 288
Nick Perrin, Finance Director
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell Tel: 020 7496 3000
Michael Taylor
Liz Yong
James Hopton
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEFMGMZZVRGRZM
(END) Dow Jones Newswires
February 16, 2018 07:45 ET (12:45 GMT)
Cvs (LSE:CVSG)
Historical Stock Chart
From Apr 2024 to May 2024
Cvs (LSE:CVSG)
Historical Stock Chart
From May 2023 to May 2024